PHAT icon

Phathom Pharmaceuticals
PHAT

Overview Fund Activity

114 hedge funds and large institutions have $588M invested in Phathom Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 35 reducing their positions, and 16 closing their positions.

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
1.65%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.13%
New
13
Increased
40
Reduced
35
Closed
16
Calls
$811K
Puts
$991K
Net Calls
-$180K
Net Calls Change
-$518K

Top Buyers

1
MVM
1
Medicxi Ventures Management
Jersey
$79.3M
2
Jennison Associates
2
Jennison Associates
New York
$17.5M
3
PBM
3
Propel Bio Management
California
$9.24M
4
OCA
4
Octagon Capital Advisors
New York
$4.83M
5
6CM
5
683 Capital Management
New York
$17.5M

Top Sellers

1
TPC
1
Takeda Pharmaceutical Company
Japan
$33.5M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$223K
3
WP
3
Woodline Partners
California
$6.02M
4
NM
4
Newtyn Management
New York
$1.75M
5
GGHC
5
Gilder Gagnon Howe & Co
New York
$10.8M
Name Market Value Shares Shares
Change 		Shares
Change %
FLSM
1
Frazier Life Sciences Management
California
$107M 10,109,279 – –
MVM
2
Medicxi Ventures Management
Jersey
$79.3M 7,464,572 +3,703,703 +98%
CG
3
Carlyle Group
District of Columbia
$37.1M 3,496,808 – –
Invesco
4
Invesco
Georgia
$33.6M 3,159,789 -7,864 -0.2%
TPC
5
Takeda Pharmaceutical Company
Japan
$33.5M 3,153,217 -4,306,069 -58%
BlackRock
6
BlackRock
New York
$29.2M 2,745,380 +66,489 +2%
Ensign Peak Advisors
7
Ensign Peak Advisors
Utah
$24.2M 2,280,000 – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$21M 1,979,113 +22,684 +1%
NMC
9
NEA Management Company
Maryland
$20.8M 1,960,169 – –
APM
10
Avidity Partners Management
Texas
$18.4M 1,735,000 +13,420 +0.8%
6CM
11
683 Capital Management
New York
$17.5M 1,650,000 +370,000 +29%
Jennison Associates
12
Jennison Associates
New York
$17.5M 1,647,697 +1,647,697 New
GGHC
13
Gilder Gagnon Howe & Co
New York
$10.8M 1,017,617 -437,515 -30%
PBM
14
Propel Bio Management
California
$9.24M 869,927 +426,880 +96%
DC
15
Decheng Capital
California
$9.03M 850,000 – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$7.98M 751,379 +16,106 +2%
CP
17
Catalys Pacific
Japan
$7.67M 721,962 – –
State Street
18
State Street
Massachusetts
$7.62M 717,201 +29,364 +4%
KCM
19
Kennedy Capital Management
Missouri
$6.08M 572,336 +360 +0.1%
GKIM
20
GW&K Investment Management
Massachusetts
$6.03M 568,026 +6,536 +1%
WP
21
Woodline Partners
California
$6.02M 566,439 -529,682 -48%
SAM
22
Simplify Asset Management
Nevada
$5.54M 521,935 +284,000 +119%
SVCM
23
Saturn V Capital Management
Texas
$5.32M 500,987 +340,912 +213%
GTC
24
Ghost Tree Capital
New York
$5.15M 485,000 +99,759 +26%
Two Sigma Investments
25
Two Sigma Investments
New York
$4.96M 467,448 +200,591 +75%
1
2 3 4 5